These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20801227)

  • 1. Thermodynamics guided lead discovery and optimization.
    Ferenczy GG; Keserũ GM
    Drug Discov Today; 2010 Nov; 15(21-22):919-32. PubMed ID: 20801227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic profiling for fragment-based lead discovery and optimization.
    Ferenczy GG; Keserű GM
    Expert Opin Drug Discov; 2020 Jan; 15(1):117-129. PubMed ID: 31741402
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of binding thermodynamics on medicinal chemistry optimizations.
    Ferenczy GG; Keserű GM
    Future Med Chem; 2015; 7(10):1285-303. PubMed ID: 26144265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A look at ligand binding thermodynamics in drug discovery.
    Claveria-Gimeno R; Vega S; Abian O; Velazquez-Campoy A
    Expert Opin Drug Discov; 2017 Apr; 12(4):363-377. PubMed ID: 28276703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of thermodynamic and kinetic data in drug discovery: decisive insight or increasing the puzzlement?
    Klebe G
    ChemMedChem; 2015 Feb; 10(2):229-31. PubMed ID: 25537429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computation of binding energies including their enthalpy and entropy components for protein-ligand complexes using support vector machines.
    Koppisetty CA; Frank M; Kemp GJ; Nyholm PG
    J Chem Inf Model; 2013 Oct; 53(10):2559-70. PubMed ID: 24050538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip?
    Geschwindner S; Ulander J; Johansson P
    J Med Chem; 2015 Aug; 58(16):6321-35. PubMed ID: 25915439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculating Water Thermodynamics in the Binding Site of Proteins - Applications of WaterMap to Drug Discovery.
    Cappel D; Sherman W; Beuming T
    Curr Top Med Chem; 2017; 17(23):2586-2598. PubMed ID: 28413953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are We There Yet? Applying Thermodynamic and Kinetic Profiling on Embryonic Ectoderm Development (EED) Hit-to-Lead Program.
    Wang Y; Edalji RP; Panchal SC; Sun C; Djuric SW; Vasudevan A
    J Med Chem; 2017 Oct; 60(20):8321-8335. PubMed ID: 28926243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of lipophilic efficiency on compound quality.
    Tarcsay A; Nyíri K; Keseru GM
    J Med Chem; 2012 Feb; 55(3):1252-60. PubMed ID: 22229549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamics of the temperature-induced unfolding of globular proteins.
    Khechinashvili NN; Janin J; Rodier F
    Protein Sci; 1995 Jul; 4(7):1315-24. PubMed ID: 7670374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry-driven Hit-to-lead Optimization Guided by Structure-based Approaches.
    Hoffer L; Muller C; Roche P; Morelli X
    Mol Inform; 2018 Sep; 37(9-10):e1800059. PubMed ID: 30051601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery.
    Williams G; Ferenczy GG; Ulander J; Keserű GM
    Drug Discov Today; 2017 Apr; 22(4):681-689. PubMed ID: 27916639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding thermodynamics of substituted diaminopyrimidine renin inhibitors.
    Sarver RW; Peevers J; Cody WL; Ciske FL; Dyer J; Emerson SD; Hagadorn JC; Holsworth DD; Jalaie M; Kaufman M; Mastronardi M; McConnell P; Powell NA; Quin J; Van Huis CA; Zhang E; Mochalkin I
    Anal Biochem; 2007 Jan; 360(1):30-40. PubMed ID: 17113558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying thermodynamic profiling in lead finding and optimization.
    Klebe G
    Nat Rev Drug Discov; 2015 Feb; 14(2):95-110. PubMed ID: 25614222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ligand efficiency metrics in drug discovery.
    Hopkins AL; Keserü GM; Leeson PD; Rees DC; Reynolds CH
    Nat Rev Drug Discov; 2014 Feb; 13(2):105-21. PubMed ID: 24481311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDBcal: a comprehensive dataset for receptor-ligand interactions with three-dimensional structures and binding thermodynamics from isothermal titration calorimetry.
    Li L; Dantzer JJ; Nowacki J; O'Callaghan BJ; Meroueh SO
    Chem Biol Drug Des; 2008 Jun; 71(6):529-32. PubMed ID: 18482338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How are fragments optimized? A retrospective analysis of 145 fragment optimizations.
    Ferenczy GG; Keserű GM
    J Med Chem; 2013 Mar; 56(6):2478-86. PubMed ID: 23437770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging the contribution of thermodynamics in drug discovery with the help of fluorescence-based thermal shift assays.
    Hau JC; Fontana P; Zimmermann C; De Pover A; Erdmann D; Chène P
    J Biomol Screen; 2011 Jun; 16(5):552-6. PubMed ID: 21441415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.